Pharmgrade Inc

Pharmgrade Inc, based in the US, specializes in biological solutions that enhance soil health and agricultural productivity, offering sustainable products that support environmentally-friendly farming practices. Founded in 1985 by Kelly Tuttle and headquartered in Idaho Falls, US, Pharmgrade Inc focuses on developing biological products for agriculture. The company has not undergone significant strategic pivots since its inception and does not have any known subsidiaries. Its unique offerings stem from over 30 years of research in soil health and crop management.

The company is led by a team with extensive background in agricultural sciences, although specific founder information is not disclosed. Pharmgrade has successfully closed one deal to date, with the most recent being an acquisition by HGS BioScience on January 9, 2026. Pharmgrade specializes in biological solutions aimed at enhancing soil health and agricultural productivity. Their core offerings include a sustainable nitrogen supplement that facilitates atmospheric nitrogen fixation, thereby reducing reliance on synthetic fertilizers.

Additionally, their flagship product is a broad-spectrum inoculant, developed over 30 years of research, which restores microbial balance and optimizes growing conditions within the soil. The company also provides a powder inoculant for dry-land applications and a late-season biological solution tailored for root crops. Pharmgrade serves a diverse clientele, including farmers and agricultural producers across North America and over 40 countries worldwide, focusing on sustainable farming practices that promote both crop resilience and environmental stewardship. Pharmgrade operates with a business model that emphasizes partnerships and B2B transactions with agricultural producers.

Their revenue is primarily generated through the sale of their biological products, which are designed for easy application and integration into existing farming practices. The company offers a variety of products, including their flagship broad-spectrum inoculant and sustainable nitrogen supplement, which are priced to reflect the value they bring in terms of improved crop yields and soil health. Transactions may occur directly with farmers or through distributors, ensuring a wide reach of their innovative solutions. By focusing on proven, research-backed formulations, Pharmgrade enhances the financial viability of agricultural operations for their clients while promoting sustainable practices.

In January 2026, HGS BioScience acquired Pharmgrade Inc, a move that aims to enhance HGS BioScience's manufacturing capabilities. The acquisition is expected to support the development and launch of new biological products in the near future. Pharmgrade is looking to expand into new geographic markets, particularly targeting regions in Europe and South America, by leveraging the strengths gained through the acquisition. This strategic shift aims to diversify their market presence and increase product accessibility on a global scale.